Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Time for a Surgeon General-ectomy?
President-elect Obama has reportedly chosen Sanjay Gupta, CNN’s chief medical correspondent and one of People magazine’s “sexiest men alive,” for the post of…
Newsletter
Bailout Fallout, the New (Green) Deal and Scaring Parents with Toxic Arguments
The House and Senate agree on a $700 billion financial bailout bill. Environmentalists try to leverage the mortgage and Wall Street financial crisis to argue…
Citation
the presidential candidates’ views on the biotech industry
Citation
FDA approval for “biogeneric” drugs
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.
Newsletter
Stem Cells, Regulating Lawn Mowers and Standing up to the SEC
The National Academy of Sciences argues for continued use of embryonic stem cells. The Environmental Protection Agency requires that new gas-powered lawn mowers come with…